BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17613764)

  • 21. The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.
    Meissner B; Kridel R; Lim RS; Rogic S; Tse K; Scott DW; Moore R; Mungall AJ; Marra MA; Connors JM; Steidl C; Gascoyne RD
    Blood; 2013 Apr; 121(16):3161-4. PubMed ID: 23407552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
    Fang NY; Greiner TC; Weisenburger DD; Chan WC; Vose JM; Smith LM; Armitage JO; Mayer RA; Pike BL; Collins FS; Hacia JG
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5372-7. PubMed ID: 12697903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An aggressive B-cell lymphoma with rearrangements of MYC and CCND1 genes: a rare subtype of double-hit lymphoma.
    Durot E; Patey M; Luquet I; Gaillard B; Kolb B; Delmer A
    Leuk Lymphoma; 2013 Mar; 54(3):649-52. PubMed ID: 22784333
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
    J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Milani R; Bardi A; Minotto C; Agostini P; De Angeli C; Narducci MG; Sabbioni S; Russo G; Negrini M; Castoldi G
    J Clin Oncol; 2000 Jul; 18(13):2607-14. PubMed ID: 10893293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
    Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
    Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
    Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
    Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
    Mareckova A; Malcikova J; Tom N; Pal K; Radova L; Salek D; Janikova A; Moulis M; Smardova J; Kren L; Mayer J; Trbusek M
    Leuk Lymphoma; 2019 Jun; 60(6):1420-1428. PubMed ID: 30626249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood complete remission after splenic irradiation in mantle-cell lymphoma with 11q22-23 deletion and ATM inactivation.
    Filippi AR; Franco P; Galliano M; Ricardi U
    Radiat Oncol; 2006 Sep; 1():35. PubMed ID: 16956411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.
    Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E
    Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
    [No Abstract]   [Full Text] [Related]  

  • 32. Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.
    Kodet R; Mrhalová M; Krsková L; Soukup J; Campr V; Neskudla T; Szépe P; Plank L
    Virchows Arch; 2003 Jun; 442(6):538-47. PubMed ID: 12728315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
    Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS
    Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma.
    Schneider S; Crescenzi B; Schneider M; Ascani S; Hartmann S; Hansmann ML; Falini B; Mecucci C; Tiacci E; Küppers R
    Int J Cancer; 2014 Feb; 134(4):832-43. PubMed ID: 23929122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma.
    Stefancikova L; Moulis M; Fabian P; Ravcukova B; Vasova I; Muzik J; Malcikova J; Falkova I; Slovackova J; Smardova J
    Int J Oncol; 2010 Mar; 36(3):699-706. PubMed ID: 20126990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mantle cell lymphoma lacking the t(11;14) translocation: a case report and brief review of the literature.
    Hunt KE; Reichard KK; Wilson CS
    J Clin Pathol; 2008 Jul; 61(7):869-70. PubMed ID: 18587018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo.
    Vogt N; Abramov D; Koch K; Masqué-Soler N; Szczepanowski M; Klapper W
    Leuk Lymphoma; 2015 Jul; 56(7):2134-40. PubMed ID: 25315075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Uncommon Case of Double-Hit Mantle Cell Lymphoma That Demonstrates a Transformation Process.
    Zhou J; Hu L; Zuo M; Zhou Y; Li G; Zhang X
    Am J Clin Pathol; 2020 Jan; 153(1):49-57. PubMed ID: 31433838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mantle cell lymphoma: a biological and therapeutic paradigm.
    Decaudin D
    Leuk Lymphoma; 2002 Apr; 43(4):773-81. PubMed ID: 12153164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytogenetic study of mantle cell lymphoma].
    Wang DM; Fan L; Fang C; Zhu DX; Dong H; Yang H; Qiu HR; Hong M; Qiao C; Xu W; Li JY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):283-6. PubMed ID: 21644224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.